No abstract available
MeSH terms
-
Adaptive Immunity*
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Neutralizing / therapeutic use
-
Antiviral Agents / pharmacology
-
Antiviral Agents / therapeutic use*
-
Betacoronavirus* / drug effects
-
Betacoronavirus* / genetics
-
Betacoronavirus* / immunology
-
Betacoronavirus* / pathogenicity
-
COVID-19
-
Coronavirus Infections* / drug therapy
-
Coronavirus Infections* / immunology
-
Coronavirus Infections* / prevention & control
-
Coronavirus Infections* / therapy
-
Drug Development
-
Humans
-
Immunization, Passive*
-
Pandemics* / prevention & control
-
Pneumonia, Viral* / drug therapy
-
Pneumonia, Viral* / immunology
-
Pneumonia, Viral* / prevention & control
-
Pneumonia, Viral* / therapy
-
Randomized Controlled Trials as Topic / economics
-
SARS-CoV-2
-
Time Factors
-
Viral Vaccines* / immunology
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Neutralizing
-
Antiviral Agents
-
Viral Vaccines